- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 26.03. | NeuroOne begins neuroablation system launch in U.S. | ||
| 26.03. | Boston Scientific, Scivita partner on endoscopic devices | ||
| 25.03. | GE HealthCare to distribute newly FDA-cleared remote patient support tech | ||
| 25.03. | Fast Company names 10 medtech companies as most innovative of 2024 | ||
| 25.03. | Precision Neuroscience launches new BCI study sites | ||
| 25.03. | Abbott wins CE mark for insertable cardiac monitor | ||
| 25.03. | FDA clears Neuronetics' neurostim for adolescents with depression | ||
| 25.03. | Axonics stockholders approve Boston Scientific acquisition | ||
| 25.03. | J&J's Biosense Webster submits Varipulse pulsed field ablation system for FDA approval | ||
| 22.03. | Masimo looks to separate consumer business two years after $1 billion buyout | ||
| 22.03. | Revamp Medical names Mike Favet as CEO | ||
| 22.03. | Biotronik wins breakthrough nod for Freesolve BTK resorbable magnesium scaffold | ||
| 22.03. | Bessel launches accelerator program for medtech startups | ||
| 21.03. | PTAB upholds two Medtronic patents in spat with Axonics, could go to jury trial | ||
| 21.03. | FDA adds SetPoint Medical and its multiple sclerosis-treating neuromod to advisory program | ||
| 21.03. | Hologic CFO: 'Mass layoffs are a failure of leadership' | ||
| 21.03. | Flosonics raises $20M for wearable ultrasound patch | ||
| 21.03. | Onward raises $22M to support neurostim tech | ||
| 21.03. | J&J's Abiomed has a Class I Impella recall with 49 deaths related to issue | ||
| 21.03. | Elixir Medical wins FDA breakthrough designation for DynamX BTK implant | ||
| 21.03. | BD ups domestic syringe production in wake of FDA warnings on syringes made in China | ||
| 21.03. | FDA clears self-driving mobile C-arm from Siemens Healthineers | ||
| 21.03. | Neuralink says patient used brain chip to play chess online | ||
| 21.03. | Stryker completes acquisition of SERF SAS | ||
| 21.03. | Intuitive Ion wins regulatory approval in China |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
